Geng Xu

564 total citations
30 papers, 387 citations indexed

About

Geng Xu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Geng Xu has authored 30 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 10 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Geng Xu's work include Cardiac pacing and defibrillation studies (5 papers), Acute Myocardial Infarction Research (5 papers) and Cardiac Arrhythmias and Treatments (4 papers). Geng Xu is often cited by papers focused on Cardiac pacing and defibrillation studies (5 papers), Acute Myocardial Infarction Research (5 papers) and Cardiac Arrhythmias and Treatments (4 papers). Geng Xu collaborates with scholars based in China, United States and Australia. Geng Xu's co-authors include Gang Cheng, Meixiang Xiang, Ji Ma, Jun Yang, Yufeng Qian, Peiwei Li, Yihua Wu, Xianhua Ye, Jianan Wang and Ying Zhou and has published in prestigious journals such as PLoS ONE, European Heart Journal and BioMed Research International.

In The Last Decade

Geng Xu

30 papers receiving 376 citations

Peers

Countries citing papers authored by Geng Xu

Since Specialization

Citations

This map shows the geographic impact of Geng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geng Xu more than expected).

Fields of papers citing papers by Geng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geng Xu. The network helps show where Geng Xu may publish in the future.

Co-authorship network of co-authors of Geng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Geng Xu. A scholar is included among the top collaborators of Geng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geng Xu. Geng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis and Biological Evaluation of Steviol Derivatives with Improved Cytotoxic Activity and Selectivity 2022 ·Journal of Natural Products ·(unknown), Liping Luo, Geng Xu, (unknown), Chao Xu, (unknown), (unknown), Zhengqiang Yuan, Yu Zhao	7
2	A new method to recommend left ventricular lead positions for improved CRT volumetric response and long-term prognosis 2019 ·Journal of Nuclear Cardiology ·Xinwei Zhang, Zhiyong Qian, Haipeng Tang, Wei Hua, Yangang Su, Geng Xu, (unknown), Xiaolin Xue, Jie Fan, Lin Cai, (unknown), Yao Wang, Xiaofeng Hou, Ernest Garcia, Weihua Zhou, Jiangang Zou	10
3	An S wave in ECG lead V6 predicts poor response to cardiac resynchronization therapy and long-term outcome 2019 ·Heart Rhythm ·Zeyu Jiang, Yuanhao Qiu, Zhiyong Qian, Yao Wang, (unknown), Xiaofeng Hou, Yanchun Liang, Liangrong Zheng, Geng Xu, Yangang Su, Xiang Gu, Jiangang Zou	7
4	NLRP3 inflammasome expression in peripheral blood monocytes of coronary heart disease patients and its modulation by rosuvastatin 2019 ·Molecular Medicine Reports ·Jian Zhu, Shili Wu, (unknown), Hui Li, (unknown), Geng Xu, Hongju Wang	34
5	Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study 2014 ·EP Europace ·Silin Chen, Keping Chen, Qian-min Tao, Liangrong Zheng, (unknown), Shulin Wu, Jie Fan, Geng Xu, Li Wang, Xiaohong Zhou, Shu Zhang	12
6	Toll-like receptor 2 in promoting angiogenesis after acute ischemic injury 2013 ·International Journal of Molecular Medicine ·(unknown), Ying Zhou, Haiyan Lin, Haiyang Hu, Yuxing Wang, Geng Xu	24
7	Thymosin beta4 induces angiogenesis through Notch signaling in endothelial cells 2013 ·Molecular and Cellular Biochemistry ·(unknown), Gang Cheng, Ying Zhou, Geng Xu	20
8	Dosing practice of low molecular weight heparins and its efficacy and safety in cardiovascular inpatients: a retrospective study in a Chinese teaching hospital 2012 ·BMC Cardiovascular Disorders ·Huimin Xu, (unknown), (unknown), Geng Xu, Xiaofeng Yan, Haibin Dai	2
9	Relationship between serum thymosin β4 levels and coronary collateral development 2011 ·Coronary Artery Disease ·(unknown), Gang Cheng, (unknown), Yuxing Wang, Geng Xu	7
10	Efficacy and safety of aliskiren, a direct renin inhibitor, compared with ramipril in Asian patients with mild to moderate hypertension 2011 ·Hypertension Research ·(unknown), Junren Zhu, Ningling Sun, Kan Yang, Jian Hu, Geng Xu, Huashan Hong, Ruonan Wang, (unknown), Shannon Ritter, Deborah Keefe	14
11	Efficacy and Safety of Abciximab in Diabetic Patients Who Underwent Percutaneous Coronary Intervention with Thienopyridines Loading: A Meta-Analysis 2011 ·PLoS ONE ·Yihua Wu, Yu Shi, Han Wu, (unknown), Qian� Tang, Geng Xu, Jun Yang	5
12	Plasma hyaluronan and collateral development in patients with coronary artery disease 2010 ·Coronary Artery Disease ·(unknown), (unknown), (unknown), (unknown), (unknown), Yuxing Wang, Gang Cheng, Geng Xu	3
13	Predictive value of the relative lymphocyte count in coronary heart disease 2010 ·Heart and Vessels ·(unknown), Yihua Wu, Yu Shi, Geng Xu, Jianan Wang, Meixiang Xiang, (unknown), Jun Jiang, Ji Ma	66
14	Coagulation Factor XIII-A Val34Leu Polymorphism and the Risk of Coronary Artery Disease and Myocardial Infarction in a Chinese Han Population 2010 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), (unknown), (unknown), (unknown), Jian Wang, Ji Ma, Yuping Shi, Geng Xu	8
15	Hypercholesterolaemic Serum Increases the Permeability of Endothelial Cells through Zonula Occludens‐1 with Phosphatidylinositol 3‐Kinase Signaling Pathway 2009 ·BioMed Research International ·(unknown), Geng Xu, Jianan Wang, Ji Ma, Meixiang Xiang, Peng Chen	17
16	Effect of atorvastatin on non-ischemic heart failure and matrix metalloproteinase-2 and 9 in rats 2007 ·Acta Pharmacologica Sinica ·Gang Cheng, Geng Xu, (unknown), Huihua Wang, Xiaofeng Bao	6
17	Giant left atrium 2007 ·European Heart Journal ·(unknown), Ji Ma, Geng Xu	1
18	PROTECTIVE EFFECTS OF MAGNESIUM AGAINST ISCHAEMIA–REPERFUSION INJURY THROUGH INHIBITION OF P‐SELECTIN IN RATS 2007 ·Clinical and Experimental Pharmacology and Physiology ·(unknown), Fang Lü, Meixiang Xiang, Geng Xu, (unknown), Jianan Wang	13
19	Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy 2006 ·Journal of Zhejiang University SCIENCE B ·(unknown), Geng Xu, (unknown), (unknown)	2
20	[Influence of fluvastatin on left ventricular remodeling after myocardial infarction in rats]. 2005 ·PubMed ·Zhihong Zhao, (unknown), Meixiang Xiang, Geng Xu, Guosheng Fu, Xiaofeng Bao	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact